Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma

Valentina Coccè, Davide Farronato, Anna Teresa Brini, Carla Masia, Aldo Bruno Giannì, Giovanna Piovani, Francesca Sisto, Giulio Alessandri, Francesca Angiero, Augusto Pessina

Research output: Contribution to journalArticle

Abstract

Human mesenchymal stromal cells (MSCs) have been widely investigated both for regenerative medicine and their antinflammatory/immunomodulatory capacity. However, their ability to home pathological tissues suggested the development of strategies for using MSCs as carrier to deliver drug into tumor microenvironment. MSCs obtained from different tissues can be loaded in vitro with anti-cancer drugs by a simple procedures. In this report, we studied MSCs isolated and expanded from gingival papilla (GinPa-MSCs), by testing their ability to uptake and release three important anti-neoplastic drugs: Paclitaxel (PTX), Doxorubicin (DXR) and Gemcitabine (GCB). The efficacy of drugs releasing GinPa-MSCs was studied on a pancreatic cancer cell line and confirmed in vitro against a line of tongue squamous cell carcinoma (SCC154). Our results demonstrated that GinPa-MSCs efficiently incorporate the drugs and then released them in active form and in sufficient amount to produce a dramatic inhibition of squamous cell carcinoma growth in vitro. If compared with other MSCs sources, the collection of GinPa-MSCs is poorly invasive and cells can be easily expanded and efficiently loaded with anti cancer drugs. In particular, gemcitabine loaded GinPa-MSCs provide a good "cell-mediated drug delivery system" for a future potential application in the context of the oral oncology.

Original languageEnglish
Pages (from-to)9376
JournalScientific Reports
Volume7
Issue number1
DOIs
Publication statusPublished - Aug 24 2017

Fingerprint

Mesenchymal Stromal Cells
Squamous Cell Carcinoma
Pharmaceutical Preparations
gemcitabine
In Vitro Techniques
Regenerative Medicine
Tumor Microenvironment
Drug Delivery Systems
Paclitaxel
Pancreatic Neoplasms
Tongue
Doxorubicin
Neoplasms
Cell Line
Growth

Keywords

  • Journal Article

Cite this

Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma. / Coccè, Valentina; Farronato, Davide; Brini, Anna Teresa; Masia, Carla; Giannì, Aldo Bruno; Piovani, Giovanna; Sisto, Francesca; Alessandri, Giulio; Angiero, Francesca; Pessina, Augusto.

In: Scientific Reports, Vol. 7, No. 1, 24.08.2017, p. 9376.

Research output: Contribution to journalArticle

Coccè, Valentina ; Farronato, Davide ; Brini, Anna Teresa ; Masia, Carla ; Giannì, Aldo Bruno ; Piovani, Giovanna ; Sisto, Francesca ; Alessandri, Giulio ; Angiero, Francesca ; Pessina, Augusto. / Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma. In: Scientific Reports. 2017 ; Vol. 7, No. 1. pp. 9376.
@article{49baefb55a364ad4b27d5f74cf9bddff,
title = "Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma",
abstract = "Human mesenchymal stromal cells (MSCs) have been widely investigated both for regenerative medicine and their antinflammatory/immunomodulatory capacity. However, their ability to home pathological tissues suggested the development of strategies for using MSCs as carrier to deliver drug into tumor microenvironment. MSCs obtained from different tissues can be loaded in vitro with anti-cancer drugs by a simple procedures. In this report, we studied MSCs isolated and expanded from gingival papilla (GinPa-MSCs), by testing their ability to uptake and release three important anti-neoplastic drugs: Paclitaxel (PTX), Doxorubicin (DXR) and Gemcitabine (GCB). The efficacy of drugs releasing GinPa-MSCs was studied on a pancreatic cancer cell line and confirmed in vitro against a line of tongue squamous cell carcinoma (SCC154). Our results demonstrated that GinPa-MSCs efficiently incorporate the drugs and then released them in active form and in sufficient amount to produce a dramatic inhibition of squamous cell carcinoma growth in vitro. If compared with other MSCs sources, the collection of GinPa-MSCs is poorly invasive and cells can be easily expanded and efficiently loaded with anti cancer drugs. In particular, gemcitabine loaded GinPa-MSCs provide a good {"}cell-mediated drug delivery system{"} for a future potential application in the context of the oral oncology.",
keywords = "Journal Article",
author = "Valentina Cocc{\`e} and Davide Farronato and Brini, {Anna Teresa} and Carla Masia and Giann{\`i}, {Aldo Bruno} and Giovanna Piovani and Francesca Sisto and Giulio Alessandri and Francesca Angiero and Augusto Pessina",
year = "2017",
month = "8",
day = "24",
doi = "10.1038/s41598-017-09175-4",
language = "English",
volume = "7",
pages = "9376",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma

AU - Coccè, Valentina

AU - Farronato, Davide

AU - Brini, Anna Teresa

AU - Masia, Carla

AU - Giannì, Aldo Bruno

AU - Piovani, Giovanna

AU - Sisto, Francesca

AU - Alessandri, Giulio

AU - Angiero, Francesca

AU - Pessina, Augusto

PY - 2017/8/24

Y1 - 2017/8/24

N2 - Human mesenchymal stromal cells (MSCs) have been widely investigated both for regenerative medicine and their antinflammatory/immunomodulatory capacity. However, their ability to home pathological tissues suggested the development of strategies for using MSCs as carrier to deliver drug into tumor microenvironment. MSCs obtained from different tissues can be loaded in vitro with anti-cancer drugs by a simple procedures. In this report, we studied MSCs isolated and expanded from gingival papilla (GinPa-MSCs), by testing their ability to uptake and release three important anti-neoplastic drugs: Paclitaxel (PTX), Doxorubicin (DXR) and Gemcitabine (GCB). The efficacy of drugs releasing GinPa-MSCs was studied on a pancreatic cancer cell line and confirmed in vitro against a line of tongue squamous cell carcinoma (SCC154). Our results demonstrated that GinPa-MSCs efficiently incorporate the drugs and then released them in active form and in sufficient amount to produce a dramatic inhibition of squamous cell carcinoma growth in vitro. If compared with other MSCs sources, the collection of GinPa-MSCs is poorly invasive and cells can be easily expanded and efficiently loaded with anti cancer drugs. In particular, gemcitabine loaded GinPa-MSCs provide a good "cell-mediated drug delivery system" for a future potential application in the context of the oral oncology.

AB - Human mesenchymal stromal cells (MSCs) have been widely investigated both for regenerative medicine and their antinflammatory/immunomodulatory capacity. However, their ability to home pathological tissues suggested the development of strategies for using MSCs as carrier to deliver drug into tumor microenvironment. MSCs obtained from different tissues can be loaded in vitro with anti-cancer drugs by a simple procedures. In this report, we studied MSCs isolated and expanded from gingival papilla (GinPa-MSCs), by testing their ability to uptake and release three important anti-neoplastic drugs: Paclitaxel (PTX), Doxorubicin (DXR) and Gemcitabine (GCB). The efficacy of drugs releasing GinPa-MSCs was studied on a pancreatic cancer cell line and confirmed in vitro against a line of tongue squamous cell carcinoma (SCC154). Our results demonstrated that GinPa-MSCs efficiently incorporate the drugs and then released them in active form and in sufficient amount to produce a dramatic inhibition of squamous cell carcinoma growth in vitro. If compared with other MSCs sources, the collection of GinPa-MSCs is poorly invasive and cells can be easily expanded and efficiently loaded with anti cancer drugs. In particular, gemcitabine loaded GinPa-MSCs provide a good "cell-mediated drug delivery system" for a future potential application in the context of the oral oncology.

KW - Journal Article

U2 - 10.1038/s41598-017-09175-4

DO - 10.1038/s41598-017-09175-4

M3 - Article

C2 - 28839168

VL - 7

SP - 9376

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

ER -